Torbangun (Coleus amboinicus)
Also called Coleus amboinicus, Plectranthus amboinicus, bangun-bangun, Indian borage, Cuban oregano, Mexican mint.
Best grade D across 1 graded outcome Botanical Last checked
The short answer
From 6 sourcesTorbangun is an aromatic herb that Batak women in Indonesia eat as soup after giving birth to boost milk supply. One small randomized trial without a placebo found more milk than with fenugreek or a reference tablet, but the torbangun group started lower. LactMed calls the human studies poor quality, and infant safety data are lacking.
Every graded outcome on this page
1 row · line = participantsKey facts
- Milk supply
- In 67 new mothers, torbangun soup raised milk volume 65% between days 14 and 28, vs 20% with fenugreek and 10% with a reference tablet1
- Caveat
- The torbangun group started with about 100 mL less milk a day (361 vs 454 and 467 mL), and gains were tested only within each group1
- LactMed's reading of the trial
- The torbangun group started 20–23% lower, and its milk volume never differed statistically from the control group's starting volume5
- Cochrane view
- Only one small study compared torbangun with other galactagogues, so it is unknown whether any one works better than another3
- LactMed view (revised 2026)
- Human studies are poor quality and inadequate to establish activity; a meta-analysis suggests more milk volume, but the effect on infant weight gain is uncertain5
- Infant safety
- No data exist on whether its components pass into breast milk or on safety in nursing infants5
- Blend trial
- In 120 mothers, a katuk, torbangun and papaya leaf decoction worked no differently from a katuk extract capsule over 28 days; about 3–5% had higher liver enzymes or nausea4
What it is
Torbangun (Coleus amboinicus) is an aromatic leaf eaten as soup by Batak mothers in Indonesia to boost breast milk after birth.
Forms, side by side
2 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Torbangun (Coleus amboinicus) forms compared
2 forms| 2 forms | Fresh leaf soup | Blends with katuk and papaya leaves |
|---|---|---|
| Absorption in people | Not studied.15 | Not studied.4 |
| GI tolerance | Adverse events are not described in the trial abstract; LactMed notes long traditional use in Indonesia with apparent safety.15 | About 3-5% of mothers had higher liver enzymes or nausea in a 120-person blend trial.4 |
| Studied for | Breast milk supply | Breast milk supply |
- Fresh leaf soup
- Blends with katuk and papaya leaves
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
1 graded outcome, largest study firstOne graded outcome so far. Breast milk volume in the first month after birth: a 2006 randomized trial of 67 people found an improvement.
1Breast milk volume in the first month after birth
Improved · Grade D · RCT, 67 people, 2006
Healthy mothers of full-term babies, from day 2 after birth (North Sumatra, Indonesia)
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Breast milk volume in the first month after birth | Improved | 67 | Grade D · RCT, 2006 | Healthy mothers of full-term babies, from day 2 after birth (North Sumatra, Indonesia) |
Every graded row
1 rowDGrade DBreast milk volume in the first month after birthBreast milk supplyMore milk vs comparatorsRCT
n 67 · 2006
Improved Milk volume rose 65% from day 14 to day 28 with torbangun (361 to 479 mL a day) vs 20% with fenugreek and 10% with the reference tablets; milk nutrient quality was not reduced. The torbangun group started about 100 mL a day lower than the other two groups, a difference the authors found not statistically significant.
- Design
- RCT, n = 67, 2006
- Population
- Healthy mothers of full-term babies, from day 2 after birth (North Sumatra, Indonesia)
- Form
- Torbangun leaf soup vs fenugreek capsules vs Moloco+B12 tablets (no placebo)
- Dose
- Soup from 150 g of leaves, 6 days a week
- Duration
- 30 days, then 30 days follow-up
- Source
- Reference 1 · PubMed 16672214 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
One trial, no placebo
The only randomized trial of torbangun alone compared it with two other products rather than placebo, and the arms started at different milk volumes.1
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
Interactions
0 agentsNone found in our sources.
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Torbangun and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Torbangun.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
5 groups- Breastfeeding mothers with low supply
- Galactagogues should not replace evaluation of feeding technique and other causes of low supply, and torbangun's safety for nursing infants has not been studied.5
- People with liver concerns using blends
- In a 120-mother trial of a torbangun, katuk and papaya leaf blend or katuk extract, about 3-5% had higher liver enzymes.4
- Liver
- LactMed describes one nursing mother using torbangun, fenugreek and goat's rue whose liver enzymes rose slightly and returned to normal after she stopped goat's rue and torbangun.5
- Pregnancy
- NCCIH notes that many dietary supplements have not been tested in pregnant women; the only torbangun trial started after birth, so use in pregnancy has not been studied.6
- People on medicines
- The cited sources describe no drug-interaction studies, so effects with blood thinners, diabetes drugs or sedatives are unknown.5
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
7 answersDoes torbangun increase breast milk?
Does torbangun have side effects?
Does torbangun interact with medicines?
No interaction studies or case reports were found in LactMed or PubMed, so effects with other medicines are unknown rather than ruled out.5
Is torbangun safe while breastfeeding?
It has long traditional use in Indonesia, but there are no data on what passes into milk or on infant safety.5
Is torbangun the same as Coleus forskohlii?
No. Torbangun is Coleus amboinicus; Coleus forskohlii is a related plant sold for forskolin.5
How was it used in the study?
What did the Cochrane review conclude?
It found only one small study for each pairing of galactagogues, including torbangun, so it could not say whether any one works better.3
Sources
6 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
6 sources- 1Lactagogue effects of Torbangun, a Bataknese traditional cuisine.RCT Asia Pac J Clin Nutr, 2006 · PMID 16672214
- 2Torbangun (Coleus amboinicus Lour): a Bataknese traditional cuisine perceived as lactagogue by Bataknese lactating women in Simalungun, North Sumatera, Indonesia.Observational J Hum Lact, 2009 · PMID 18984829
- 3Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants.Systematic review Cochrane Database Syst Rev, 2020 · PMID 32421208
- 4Galactagogue activity of poly-herbal decoction from Indonesia: a randomized open label controlled trial.RCT J Complement Integr Med, 2024 · PMID 38644615
- 5Coleus. Drugs and Lactation Database (LactMed)Database National Library of Medicine (NCBI Bookshelf), 2026 · ncbi.nlm.nih.gov
- 6Using Dietary Supplements WiselyFact sheet National Center for Complementary and Integrative Health (NCCIH), 2019 · nccih.nih.gov
What changed
Every dated change to this page: what changed, who made it and why.
Change log
3 entries| Date | Change | Who and why |
|---|---|---|
| key facts, evidence notes, FAQ | Added LactMed's reading of the 2006 trial (lower starting volume, no difference from the control group's baseline) and the 120-mother blend trial (PMID 38644615) to key facts; added FAQ on side effects and interactions. PubMed search through 2026 found no newer oral trial of torbangun alone; LactMed lists no drug interactions. | Writer: Kymata Health EditorialTrigger: A–Z page audit |
| who should avoid | Pregnancy caution re-sourced to NCCIH (agency source) instead of the trial report | Writer: Kymata Health EditorialTrigger: adversarial review |
| all | Initial editorial evidence review | Writer: Kymata Health EditorialTrigger: new page |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.